LabStyle Innovations Ltd.

LabStyle Innovations Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on December 21, 2015 and the most recent on December 21, 2015 (Dario Blood Glucose Monitoring System). Its most common review panel is Clinical Chemistry (1 device).